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The surgical outcome was evaluated in 14 patients over 80 
years of age with non-small cell lung cancer. 
 The satisfactory results are predicted as far as surgical 
indication is limited to favorable candidates. Further post-
operative cares for age-related diseases are required in a 
follow-up study. 
 It is documented in 1989 that the mean survival age of 
70 years old is 15.8 years in life and that of 80 years old is 
8.67 years in Japan.1) However, the mean survival age is 
now tremendously increasing. The major items of concern 
include therapeutic choice for elderly patients with malig-
nant disease. The surgical indication for lung cancer pa-
tients of the aged is shifting from 70 years of age to 80. 
 In this study, the validity of surgery for patients over 80 
years of age is assessed on the basis of a result of clinical 
experience.
Table 1. Staging in the aged over 80 years of age
   Disease stage Cases % 
       I 8 57.1
       II 1 7.1 
      ]IIA 3 21.4
       ]IIB 1 7.1 
       N 1 7.1
            Table 2. Operative procedures 
  procedures cases % nodal dissection 
partial resection 2 14.2 Ro 8(S7.1%) 
segmentectomy 5 35.7 R, 3(21.4%) 
lobectomy 7 50.0 R2 1 ( 7.1%) 
                                R3 1(7.1%)
Patients 
During the 10 years from January 1983 to December 1992, 
14 patients over 80 years of age underwent surgical resec-
tion at the First Department of Surgery, Nagasaki Univer-
sity School of Medicine. 
  The men to women ratio was 11:3 and males were 
predominant in a ratio of 3.6:1. Histologic types were 
adenocarcinoma in 10 and squamous cell carcinoma in 
four, respectively. 
  Preoperatively associated diseases were hypertension in 
six (42.9%), old myocardial infarction in one (7.1%) and 
abnormal ECG findings (atrial fibrillation in one and ST-T 
in two) in three (21.4%). According to the disease stages as 
shown in Table 1, eight were of stage I, one was stage II, 
there were stage III A, one stage IIIB and one stage IV, respec-
tively. 
 Preoperative pulmonary function test indicated the slight 
degree of obstructive ventilatory failure which was 71.0 of 
FEV,_o on the average (59.3 to 79.5) and 103.7 (87.8 to 
122.5) of %VC. Table 2 represented the operative proce-
dures, of which two were partial resection (14.2%), five
segmentectomy (35.7%), seven lobectomy (50.0%) includ-
ing combined resection with thoracic wall in one. Main 
procedures were lobectomy and segmentectomy. However, 
incomplete nodal dissection in older patients was made in 
selected cases. 
 The operative result were shown in Table 3. Post-
operative complications were encountered in three, alveolar 
fistula in two and pneumonia in one. There was no ominous 
complications and drug controllable arrythmia appeared in 
two. No operative death was encountered in this series. The 
surgical outcome was revealed in Table 4. Eight patients 
were living well. Six died of recurrence and unrelated 
causes in three.
Table 3. Operative results
                                 cases % 
Operative death 0 
Complication 
 arrythmia 2 (15.4) 
 alveolar fistula 2 (15.4) 
 pneumonia 1 (7.7)
 Unrelated causes included senile malasmus, intracranial 
bleeding and heart failure. Cumulative survival curve was
represented in Fig. 1. It is assumed that survivors over two 
years after surgery ensured a satisfactory outcome. And 
also attention should be paid to the fact that postoperative 
care for age-related diseases is required for predicting a 
longer survival following surgery.
Fig. 1. Cummulative Survival Curves
Discussion 
Recently surgery has been increasing in number. In partic-
ular, surgery is mandatory for non-small cell lung cancer 
patients. Needless to say, surgery is an essential treatment 
of choice. There is no other valuable way of treatment for 
non-small cell lung cancer patients. 
 In this study, the validity of surgery for patients over 80 
years of age was evaluated. Indications of surgery are 
limited to stage I and II patients as compared with younger 
patients. As a result, candidates for surgery should be 
selected. This may be contributory to better surgical out-
come. 
 It is generally accepted that surgery should be indicated 
for patients with completely resectable tumors, dissectable 
nodes, no evidence of distant metastasis and general condi-
tion ensuring operation-tolerance. 
 Functional assessment for surgical indication differs 
between younger and older patients with lung cancer. In 
particular, determination of surgical indication for patients 
over 80 years of age should be prudent and seriously taken 
into consideration. 
 As far as surgical indication is carefully limited, surgical 
outcome is satisfactory. Furthermore, it should be empha-
sized that excellent result can be expected in those who 
survive over two years after surgery. It is concluded that 
age factor over 80 years of age should not be excluded 
from surgical indication."' 
 Functional indication used to be considered in a range of 
800ml/m2 of VC and 600m1/m2 of FVC.4'5' The incidence of 
postoperative complications is said to be high in occurrence 
in older patients.b' In contrast, Martini" reported a low 
mortality rate of 2% in the elderly over 80years of age. 
  A five year survival rate ranged from 27 to 30%.8.9' As 
far as stage I patients are indicated, a fair survival rate is 
predicted even in patients over 80 years of age who are 
overcoming age-related diseases. 
  It should be taken into consideration that the immune 
respose of older patients is affected and also postoperative 
recovery is retarded. For these reasons, the indication of 
surgery should be limited and selected. 
  On the other hand, attention to psychological disturbance 
in older patients should be paid for determination of sur-
gical indication in resuming an enjoyable postoperative life.
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